Physician profile
Ramesh Krishnan
NPI 1922095165
$26,084.92
in general payments reported to CMS, 2019-2025
44 companies · $1,563 in 2025
The $1,563 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,356 · 2021: $833 · 2022: $1,018 · 2023: $1,671 · 2024: $1,124 · 2025: $1,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,358.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14,286.56 | 2019-2023 | Aveed, Xiaflex |
| Coloplast Corp | $2,270.82 | 2019-2025 | Titan, Altis, Porges Coloplast |
| Allergan, INC. | $2,250.71 | 2019-2022 | |
| Boston Scientific Corporation | $1,662.15 | 2019-2023 | Rezum Generator, Ams 700 |
| Abbvie INC. | $974.64 | 2019-2025 | |
| Angiodynamics, INC. | $506.95 | 2023-2025 | Nanoknife, Solero, Biosentry Tract Sealant System |
| Teleflex LLC | $320.49 | 2025 | Urolift, Barrigel |
| E.R. Squibb & Sons, L.L.C. | $318.68 | 2019-2022 | |
| Astellas Pharma US INC | $312.44 | 2019-2025 | Xtandi, Padcev |
| Janssen Pharmaceuticals, INC | $271.68 | 2019-2020 | |
| 180 Medical, INC. | $232.15 | 2019-2024 | Gentlecath |
| C. R. Bard, INC. & Subsidiaries | $208.45 | 2019-2023 | Bard Urinary Drainage Bag |
| Medtronic, INC. | $185.64 | 2024 | Interstim, Situate |
| Procept Biorobotics Corporation | $171.42 | 2019-2025 | Aquabeam System |
| Endo USA, INC. | $170.43 | 2024-2025 | Xiaflex |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $145.23 | 2020 | |
| Calyxo, INC. | $140.59 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $131.91 | 2023-2024 | Axonics |
| Rochester Medical Corporation | $118.46 | 2021-2022 | |
| Amarin Pharma, INC. | $118.25 | 2020 | |
| Neotract INC. | $111.30 | 2019 | |
| Olympus America INC. | $110.82 | 2023-2025 | Itind System, Soltive |
| Convatec INC. | $102.90 | 2019-2021 | |
| Agiliti Surgical, INC. | $101.95 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu, Lumenis Pulse 120h Holmium Laser System With Moses 2.0 Technology |
| Paratek Pharmaceuticals, INC. | $96.19 | 2023 | Nuzyra |
| Progenics Pharmaceuticals, INC. | $94.27 | 2023-2024 | Pylarify |
| Antares Pharma, INC. | $88.41 | 2021-2024 | Xyosted |
| Pfizer INC. | $77.80 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $70.87 | 2023-2025 | Gemtesa, Orgovyx |
| Dornier Medtech America, INC | $70.51 | 2019 | |
| Intuitive Surgical, INC. | $45.26 | 2024 | |
| Edap Technomed INC | $39.23 | 2023 | |
| Myriad Genetic Laboratories, INC. | $31.95 | 2025 | Prolaris |
| Amgen INC. | $30.92 | 2019-2020 | |
| Janssen Biotech, INC. | $30.26 | 2019 | |
| Tolmar, INC. | $26.55 | 2025 | Jatenzo, Eligard |
| Mission Pharmacal Company | $26.46 | 2019 | |
| Ambu INC. | $25.12 | 2024 | |
| Telix Pharmaceuticals | $23.40 | 2024 | Illuccix |
| Laborie Medical Technologies Corp. | $18.72 | 2022 | |
| Blue Earth Diagnostics | $17.72 | 2022 | |
| Caldera Medical, INC | $17.67 | 2021 | |
| Myovant Sciences INC. | $15.00 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.